The stability of G6PD is affected by mutations with different clinical phenotypes.
about
Glucose-6-Phosphate Dehydrogenase: Update and Analysis of New Mutations around the WorldThe challenges of introducing routine G6PD testing into radical cure: a workshop report.Prevalence and Molecular Characterization of Glucose-6-Phosphate Dehydrogenase Deficiency at the China-Myanmar BorderCoupling between Protein Stability and Catalytic Activity Determines Pathogenicity of G6PD Variants.A trade off between catalytic activity and protein stability determines the clinical manifestations of glucose-6-phosphate dehydrogenase (G6PD) deficiency.Detailed functional analysis of two clinical glucose-6-phosphate dehydrogenase (G6PD) variants, G6PDViangchan and G6PDViangchan+Mahidol: Decreased stability and catalytic efficiency contribute to the clinical phenotype.Functional and Biochemical Characterization of Three Recombinant Human Glucose-6-Phosphate Dehydrogenase Mutants: Zacatecas, Vanua-Lava and Viangchan.Mutations of Glucose-6-Phosphate Dehydrogenase Durham, Santa-Maria and A+ Variants Are Associated with Loss Functional and Structural Stability of the Protein.Biochemical Analysis of Two Single Mutants that Give Rise to a Polymorphic G6PD A-Double Mutant.A novel flow cytometry-based method of analyzing Heinz bodies.Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency among malaria patients in Upper Myanmar.Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries.Biochemical Characterization and Structural Modeling of Fused Glucose-6-Phosphate Dehydrogenase-Phosphogluconolactonase from
P2860
Q28074566-A20DBF2E-6076-4F5A-A02F-69FACA06A7F3Q30666192-A4138741-E9BB-47A3-A598-EBA2475A6128Q35727140-6AA067D6-E73B-4DB8-817C-9AC29E2B73B6Q38905568-D834DB54-34E4-4E64-8823-34F15A17CF5EQ38914672-78C03508-CAFB-4ABB-A895-C92D54281EA7Q38914675-1DC9254D-16FF-4DB3-80B8-46307108364CQ42759344-155DE8EE-DFCD-47CD-8E5C-5DADDEFFC5BBQ43116428-A5033F72-6A6B-44DF-ACEF-F91F672225C5Q48050647-A23C47EA-0438-49C7-A6E1-88B359113471Q48152696-93FB5D75-6C3D-4923-9038-FD6D9B6FBA45Q51762424-F9E6AB17-5E4A-40B8-82AE-4FCDA643782CQ53691594-9A7F118C-B6E9-4FD6-9513-B9E552C9B9E4Q57167498-F0E8B10A-D945-48EE-8DAE-47AA9BD28FE4
P2860
The stability of G6PD is affected by mutations with different clinical phenotypes.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The stability of G6PD is affected by mutations with different clinical phenotypes.
@ast
The stability of G6PD is affected by mutations with different clinical phenotypes.
@en
The stability of G6PD is affected by mutations with different clinical phenotypes.
@nl
type
label
The stability of G6PD is affected by mutations with different clinical phenotypes.
@ast
The stability of G6PD is affected by mutations with different clinical phenotypes.
@en
The stability of G6PD is affected by mutations with different clinical phenotypes.
@nl
prefLabel
The stability of G6PD is affected by mutations with different clinical phenotypes.
@ast
The stability of G6PD is affected by mutations with different clinical phenotypes.
@en
The stability of G6PD is affected by mutations with different clinical phenotypes.
@nl
P2093
P2860
P50
P356
P1476
The stability of G6PD is affected by mutations with different clinical phenotypes
@en
P2093
Abigail González-Valdez
America Vanoye-Carlo
Gabriel López-Velázquez
Gloria Hernández-Alcántara
Ignacio De la Mora-De la Mora
Itzhel García-Torres
Jessica Terrón-Hernández
Sergio Enríquez-Flores
P2860
P304
21179-21201
P356
10.3390/IJMS151121179
P407
P577
2014-11-17T00:00:00Z